MicroRNA-31 targets thymic stromal lymphopoietin in mucosal infiltrated CD4+ T cells: : a role in achieving mucosal healing in ulcerative colitis?
MicroRNA-31 targets thymic stromal lymphopoietin in mucosal infiltrated CD4+ T cells: : a role in achieving mucosal healing in ulcerative colitis?
Background: Ulcerative colitis (UC) is characterized by disruption of the mucosal intestinal barrier. MicroRNAs, single-stranded noncoding RNAs of approximately 22nt, are dysregulated in UC. MicroRNAs targeting thymic stromal lymphopoietin (TSLP), a cytokine involved in T-cell maturation and polarization, may be involved in regulating UC inflammation and mucosal healing.
Methods: Biopsy samples from non-UC (n = 38), inactive UC (n = 18), and active UC (n = 23) patients were analyzed for mRNA (real-time quantitative polymerase chain reaction) or TSLP protein expression (enzyme-linked immunosorbent assay). Flow cytometry was used to isolate CD4+ T cells from biopsies. The functional mechanism was shown using luciferase assays and antago-miR transfections. The TSLP/miR-31 association was analyzed on 196 subjects from a previous clinical trial that tested the anti-IL-13 drug tralokinumab, whereas mucosal healing effects were studied on a subset of patients (n = 13) from this trial.
Results: We found that TSLP is reduced at both mRNA and protein levels in inflamed UC patients when compared with healthy subjects, in both whole biopsies and biopsy-isolated CD4+ CD25+ T cells. The expression of miR-31, predicted to target TSLP, inversely co-related to the levels of TSLP mRNA in T cells. Blocking miR-31 in vitro in T cells increased both TSLP mRNA expression and protein secretion. Luciferase assays showed that miR-31 directly targeted TSLP mRNA, suggesting a direct mechanistic link. We also found that TSLP is increased in patients who achieve mucosal healing, comparing biopsies before and after treatment from the tralokinumab trial.
Conclusions:
Our data suggest a role for TSLP in promoting mucosal healing and regulating inflammation in UC, whereas miR-31 can directly block this effect.
2377–2385
Whiteoak, Simon R.
e733e00f-0927-4bed-80a3-eb8d4b06945c
Claridge, Andrew
2f9c856c-488f-4de9-9b5b-85b591f9d66c
Balendran, Clare A.
0b9d5d4f-71a6-4cd9-89a1-b174618192a8
Harris, Richard J.
8cc2fa3d-aab1-4fb4-b0b8-ad516cf5a08b
Gwiggner, Markus
af72b597-1ead-4155-a25c-0835f7e560c2
Bondanese, Victor P.
3a4cee7f-961a-43af-b011-12170923984b
Erlandsson, Fredrik
d8903cc5-fb59-4f19-af2c-e3e698f86297
Hansen, Mark Berner
99e90097-1ed6-4335-960a-a6ba8c55fdea
Cummings, J.R. Fraser
89e8e80c-b6e8-4387-a63c-3796b5ad7e14
Sanchez-Elsner, Tilman
b8799f8d-e2b4-4b37-b77c-f2f0e8e2070d
November 2018
Whiteoak, Simon R.
e733e00f-0927-4bed-80a3-eb8d4b06945c
Claridge, Andrew
2f9c856c-488f-4de9-9b5b-85b591f9d66c
Balendran, Clare A.
0b9d5d4f-71a6-4cd9-89a1-b174618192a8
Harris, Richard J.
8cc2fa3d-aab1-4fb4-b0b8-ad516cf5a08b
Gwiggner, Markus
af72b597-1ead-4155-a25c-0835f7e560c2
Bondanese, Victor P.
3a4cee7f-961a-43af-b011-12170923984b
Erlandsson, Fredrik
d8903cc5-fb59-4f19-af2c-e3e698f86297
Hansen, Mark Berner
99e90097-1ed6-4335-960a-a6ba8c55fdea
Cummings, J.R. Fraser
89e8e80c-b6e8-4387-a63c-3796b5ad7e14
Sanchez-Elsner, Tilman
b8799f8d-e2b4-4b37-b77c-f2f0e8e2070d
Whiteoak, Simon R., Claridge, Andrew, Balendran, Clare A., Harris, Richard J., Gwiggner, Markus, Bondanese, Victor P., Erlandsson, Fredrik, Hansen, Mark Berner, Cummings, J.R. Fraser and Sanchez-Elsner, Tilman
(2018)
MicroRNA-31 targets thymic stromal lymphopoietin in mucosal infiltrated CD4+ T cells: : a role in achieving mucosal healing in ulcerative colitis?
Inflammatory Bowel Diseases, 24 (11), .
(doi:10.1093/ibd/izy213).
Abstract
Background: Ulcerative colitis (UC) is characterized by disruption of the mucosal intestinal barrier. MicroRNAs, single-stranded noncoding RNAs of approximately 22nt, are dysregulated in UC. MicroRNAs targeting thymic stromal lymphopoietin (TSLP), a cytokine involved in T-cell maturation and polarization, may be involved in regulating UC inflammation and mucosal healing.
Methods: Biopsy samples from non-UC (n = 38), inactive UC (n = 18), and active UC (n = 23) patients were analyzed for mRNA (real-time quantitative polymerase chain reaction) or TSLP protein expression (enzyme-linked immunosorbent assay). Flow cytometry was used to isolate CD4+ T cells from biopsies. The functional mechanism was shown using luciferase assays and antago-miR transfections. The TSLP/miR-31 association was analyzed on 196 subjects from a previous clinical trial that tested the anti-IL-13 drug tralokinumab, whereas mucosal healing effects were studied on a subset of patients (n = 13) from this trial.
Results: We found that TSLP is reduced at both mRNA and protein levels in inflamed UC patients when compared with healthy subjects, in both whole biopsies and biopsy-isolated CD4+ CD25+ T cells. The expression of miR-31, predicted to target TSLP, inversely co-related to the levels of TSLP mRNA in T cells. Blocking miR-31 in vitro in T cells increased both TSLP mRNA expression and protein secretion. Luciferase assays showed that miR-31 directly targeted TSLP mRNA, suggesting a direct mechanistic link. We also found that TSLP is increased in patients who achieve mucosal healing, comparing biopsies before and after treatment from the tralokinumab trial.
Conclusions:
Our data suggest a role for TSLP in promoting mucosal healing and regulating inflammation in UC, whereas miR-31 can directly block this effect.
Text
Accepted_manuscript_Whiteoak_Claridge_et_al_2018
- Accepted Manuscript
Text
Figures Whiteoak Claridge et al 2018
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 17 May 2018
e-pub ahead of print date: 8 June 2018
Published date: November 2018
Identifiers
Local EPrints ID: 421450
URI: http://eprints.soton.ac.uk/id/eprint/421450
PURE UUID: 79b18030-8dea-4fa4-b564-d8d2feb26be9
Catalogue record
Date deposited: 12 Jun 2018 16:30
Last modified: 16 Mar 2024 06:41
Export record
Altmetrics
Contributors
Author:
Simon R. Whiteoak
Author:
Andrew Claridge
Author:
Clare A. Balendran
Author:
Richard J. Harris
Author:
Markus Gwiggner
Author:
Victor P. Bondanese
Author:
Fredrik Erlandsson
Author:
Mark Berner Hansen
Author:
J.R. Fraser Cummings
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics